More on ECHQF
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.10 |
|
|||
| Open | $1.12 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $1.12 | ||||
| Day Low | $1.12 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 6,800 | ||||
- EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives
- Research Collaboration Secured to Evaluate AI-Driven Cardiac Risk Stratification in Cancer Patients
- Echo IQ Announces EchoSolv AS Deployed into Mount Sinai Health System
- Validation study for EchoSolv HF completed at the Mayo Clinic – Study delivers exceptional results
- Echo IQ to Participate in the Piper Sandler 37th Annual Healthcare Conference
- Echo IQ Highlights Market Potential for EchoSolv AS Following Presentation of New Data for Severe Aortic Stenosis (AS) Presented at AHA Scientific Sessions 2025
Entities mentioned with ECHQF
- FDA | View Related Stories »
- Carl Icahn | View Related Stories »
- Citi | View Related Stories »
- Show More...
